House sustains President's embryonic stem cell veto
This article was originally published in Clinica
The chance for stem cell legislation is over for this year. On July 19 the US House failed to muster the two-thirds margin needed to override a presidential veto of a bill expanding the number of stem cell lines available for federally funded research. The House vote was 235 to 193, the same day President Bush vetoed the bill saying it would finance "the deliberate destruction of embryos".